✦ LIBER ✦

Taxotere™ (docetaxel: DTXL), an active agent for non-small cell lung cancer (NSCLC): Preliminary report of 2 phase II studies

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1096 Preliminary report of a phase II st

✍ Douillard, J.Y.; Monnier, A.; Ibrahim, N.; Belli, L.; Sun, X.S.; Soulas, F.; Boy 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 310 KB

83 Phase II study of docetaxel (Taxotere

✍ Le Chevalier, T.; Mattson, K.; Bosquée, L.; Le Groumellec, A.; Stupp, R.; Monnie 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II study of zeniplatin, an active

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A phase I/II study of Docetaxel (Taxoter

✍ Aamdal, S; Lauvvang, G; Owre, K; Hatlevoll, R; Armellini, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Interim results of a phase II study of d

✍ Mattson, K.; Le Chevalier, T.; Bospuée, L.; Pujol, J.L.; Culine, S.; Dabouis, G. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Phase II study of docetaxel (TXT) and ca

✍ Giannakakis, T; Kakolyris, S; Papadouris, S; Theodoropoulos, I; Kalbakis, K; And 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB